Company Profiles

driven by the PitchBook Platform

ValenTx

ValenTx
2002 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$36.9M TOTAL AMOUNT RAISED
7 INVESTORS
Description

Developer of a treatment for obesity-related metabolic disorders. The company develops a therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
6901 East Fish Lake Road
Suite 118
Maple Grove, MN 55369
United States

+1 (763) 222-1560
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ValenTx’s full profile, request a free trial.

ValenTx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 11-Jul-2017 $36.9M Completed Generating Revenue
5. Convertible Debt 03-Sep-2015 00.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 04-Sep-2009 0000 000.00 0000 Completed Generating Revenue
3. Early Stage VC (Series A1) 13-Jul-2006 00.000 00.000 000.00 Completed Startup
2. Early Stage VC (Series A) 17-Feb-2005 $772k $1.34M $3.27M Completed Startup
1. Seed Round 16-Jun-2004 $570k $570k $1.57M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

ValenTx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00 00 00 0.000
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 7,654,459 $0.001000 $1.24 $1.24 1x $1.24 57.41%
To view this company’s complete Cap Table request access »

ValenTx Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Affinity Capital Management Venture Capital Minority 000 0000 000000 0
EDF Ventures Venture Capital Minority 000 0000 000000 0
Kaiser Permanente Ventures Corporate Venture Capital Minority 000 0000 000000 0
Medtronic Ventures Corporate Venture Capital Minority 000 0000 000000 0
SV Health Investors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

ValenTx Executive Team (6)

Name Title Board
Seat
Contact
Info
Jon St. Germain Chief Executive Officer & Board Member
Terry Dahl Director, Engineering
Phil Zhang MD Senior Director, Clinical Research
Allen Putnam Vice President, Clinical, Regulatory and Quality
Cole Chen Vice President, Product Development
You’re viewing 5 of 6 executives. Get the full list »

ValenTx Board Members (7)

Name Representing Role Since Contact
Info
Bob Griffin Self Board Member 000 0000
David Schulte Kaiser Permanente Ventures Board Observer 000 0000
Elizabeth Rockett Kaiser Permanente Ventures Board Member 000 0000
Jon St. Germain ValenTx Chief Executive Officer & Board Member 000 0000
Mary Campbell EDF Ventures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »